Vaccines for immunoprevention of DNA mismatch repair deficient cancers

The development of cancer vaccines to induce tumor-antigen specific immune responses was sparked by the identification of antigens specific to or overexpressed in cancer cells. However, weak immunogenicity and the mutational heterogeneity in many cancers have dampened cancer vaccine successes. With...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernandez-Sanchez, Alejandro, Grossman, Mark, Yeung, Kevin, Sei, Shizuko S, Lipkin, Steven, Kloor, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226910/
https://www.ncbi.nlm.nih.gov/pubmed/35732349
http://dx.doi.org/10.1136/jitc-2021-004416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226910/
https://www.ncbi.nlm.nih.gov/pubmed/35732349
http://dx.doi.org/10.1136/jitc-2021-004416

Ejemplares similares